36
Participants
Start Date
August 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
December 31, 2013
GC1102
"1. Description: GC1102 IV bolus injection during 10\~ 30 seconds.~2. Amount: group1-3ml, group2-5ml, group3-8ml~3. Subject number: group1-8, group2-8, group3-8~4. Administration time: 1day, 2day, 3day, 4day, 5day, 6day, 7day(total: 7 times)"
JW normal saline
"1. Description: Normal saline IV bolus injection through 10\~ 30 seconds.~ * Each 3 subjects of this placebo comparator group will match with group 1,2,3 respectively. Placebo comparator subjects in each group will be treated with same condition of each group(group 1, group 2, group 3) except being administered JW normal saline.~2. Subject number: 9~3. Administration time: 1day, 2day, 3day, 4day, 5day, 6day, 7day(total: 7 times)"
Department of clinical pharmacology and therapeutics, Seoul
Lead Sponsor
Green Cross Corporation
INDUSTRY